nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0211	0.146	CbGbCtD
Orlistat—CYP3A4—Dapsone—systemic lupus erythematosus	0.0184	0.128	CbGbCtD
Orlistat—PLA2G7—blood plasma—systemic lupus erythematosus	0.0177	0.0842	CbGeAlD
Orlistat—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.016	0.111	CbGbCtD
Orlistat—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.016	0.111	CbGbCtD
Orlistat—PNLIP—blood plasma—systemic lupus erythematosus	0.0156	0.074	CbGeAlD
Orlistat—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0137	0.095	CbGbCtD
Orlistat—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0135	0.0937	CbGbCtD
Orlistat—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0128	0.0888	CbGbCtD
Orlistat—CYP3A4—Prednisone—systemic lupus erythematosus	0.0128	0.0885	CbGbCtD
Orlistat—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0121	0.0839	CbGbCtD
Orlistat—DAGLA—tendon—systemic lupus erythematosus	0.0104	0.0492	CbGeAlD
Orlistat—DAGLB—kidney—systemic lupus erythematosus	0.00996	0.0472	CbGeAlD
Orlistat—PLA2G7—connective tissue—systemic lupus erythematosus	0.00945	0.0448	CbGeAlD
Orlistat—DAGLA—nervous system—systemic lupus erythematosus	0.00843	0.04	CbGeAlD
Orlistat—PNLIP—connective tissue—systemic lupus erythematosus	0.00831	0.0394	CbGeAlD
Orlistat—DAGLA—central nervous system—systemic lupus erythematosus	0.00811	0.0385	CbGeAlD
Orlistat—FASN—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00811	0.677	CbGdCrCtD
Orlistat—DAGLB—tendon—systemic lupus erythematosus	0.00804	0.0381	CbGeAlD
Orlistat—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00798	0.0552	CbGbCtD
Orlistat—ABHD16A—cortex of kidney—systemic lupus erythematosus	0.00735	0.0349	CbGeAlD
Orlistat—DAGLB—lung—systemic lupus erythematosus	0.00706	0.0335	CbGeAlD
Orlistat—PLA2G7—lymphoid tissue—systemic lupus erythematosus	0.00691	0.0328	CbGeAlD
Orlistat—ABHD12—cortex of kidney—systemic lupus erythematosus	0.00689	0.0327	CbGeAlD
Orlistat—PLA2G7—tendon—systemic lupus erythematosus	0.00649	0.0308	CbGeAlD
Orlistat—PLA2G4A—blood plasma—systemic lupus erythematosus	0.00629	0.0299	CbGeAlD
Orlistat—PLA2G7—bone marrow—systemic lupus erythematosus	0.00629	0.0298	CbGeAlD
Orlistat—ABHD16A—tendon—systemic lupus erythematosus	0.00609	0.0289	CbGeAlD
Orlistat—ABHD16A—bone marrow—systemic lupus erythematosus	0.0059	0.028	CbGeAlD
Orlistat—ABHD12—tendon—systemic lupus erythematosus	0.00571	0.0271	CbGeAlD
Orlistat—PLA2G7—lung—systemic lupus erythematosus	0.0057	0.027	CbGeAlD
Orlistat—ABHD16A—lung—systemic lupus erythematosus	0.00535	0.0254	CbGeAlD
Orlistat—ABHD12—lung—systemic lupus erythematosus	0.00501	0.0238	CbGeAlD
Orlistat—PNLIP—lung—systemic lupus erythematosus	0.00501	0.0238	CbGeAlD
Orlistat—FASN—lung—systemic lupus erythematosus	0.0042	0.0199	CbGeAlD
Orlistat—CYP3A4—urine—systemic lupus erythematosus	0.00398	0.0189	CbGeAlD
Orlistat—PLA2G4A—connective tissue—systemic lupus erythematosus	0.00335	0.0159	CbGeAlD
Orlistat—PLA2G4A—cortex of kidney—systemic lupus erythematosus	0.00278	0.0132	CbGeAlD
Orlistat—PLA2G4A—tendon—systemic lupus erythematosus	0.0023	0.0109	CbGeAlD
Orlistat—PLA2G4A—bone marrow—systemic lupus erythematosus	0.00223	0.0106	CbGeAlD
Orlistat—CYP3A4—blood plasma—systemic lupus erythematosus	0.00208	0.00985	CbGeAlD
Orlistat—PLA2G4A—lung—systemic lupus erythematosus	0.00202	0.00959	CbGeAlD
Orlistat—PLA2G4A—Raltitrexed—Methotrexate—systemic lupus erythematosus	0.00192	0.16	CbGdCrCtD
Orlistat—PLA2G4A—nervous system—systemic lupus erythematosus	0.00187	0.00888	CbGeAlD
Orlistat—PLA2G4A—central nervous system—systemic lupus erythematosus	0.0018	0.00855	CbGeAlD
Orlistat—CYP3A4—kidney—systemic lupus erythematosus	0.000941	0.00446	CbGeAlD
Orlistat—CYP3A4—nervous system—systemic lupus erythematosus	0.000617	0.00293	CbGeAlD
Orlistat—CYP3A4—central nervous system—systemic lupus erythematosus	0.000594	0.00282	CbGeAlD
Orlistat—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000273	0.000636	CcSEcCtD
Orlistat—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000273	0.000636	CcSEcCtD
Orlistat—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000272	0.000634	CcSEcCtD
Orlistat—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000272	0.000634	CcSEcCtD
Orlistat—Convulsion—Betamethasone—systemic lupus erythematosus	0.000272	0.000634	CcSEcCtD
Orlistat—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000271	0.000632	CcSEcCtD
Orlistat—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000271	0.000632	CcSEcCtD
Orlistat—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000269	0.000627	CcSEcCtD
Orlistat—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000269	0.000627	CcSEcCtD
Orlistat—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000268	0.000624	CcSEcCtD
Orlistat—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000267	0.000623	CcSEcCtD
Orlistat—Myalgia—Betamethasone—systemic lupus erythematosus	0.000267	0.000623	CcSEcCtD
Orlistat—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000267	0.000621	CcSEcCtD
Orlistat—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000267	0.000621	CcSEcCtD
Orlistat—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000266	0.00062	CcSEcCtD
Orlistat—Anxiety—Betamethasone—systemic lupus erythematosus	0.000266	0.00062	CcSEcCtD
Orlistat—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000264	0.000615	CcSEcCtD
Orlistat—Discomfort—Betamethasone—systemic lupus erythematosus	0.000264	0.000615	CcSEcCtD
Orlistat—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000264	0.000615	CcSEcCtD
Orlistat—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000264	0.000614	CcSEcCtD
Orlistat—Pain—Prednisolone—systemic lupus erythematosus	0.000263	0.000612	CcSEcCtD
Orlistat—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000263	0.000611	CcSEcCtD
Orlistat—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000263	0.000611	CcSEcCtD
Orlistat—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.000609	CcSEcCtD
Orlistat—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000261	0.000607	CcSEcCtD
Orlistat—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000261	0.000607	CcSEcCtD
Orlistat—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.000606	CcSEcCtD
Orlistat—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.000606	CcSEcCtD
Orlistat—Nausea—Leflunomide—systemic lupus erythematosus	0.00026	0.000605	CcSEcCtD
Orlistat—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000259	0.000604	CcSEcCtD
Orlistat—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000259	0.000603	CcSEcCtD
Orlistat—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000259	0.000602	CcSEcCtD
Orlistat—Vision blurred—Prednisone—systemic lupus erythematosus	0.000258	0.0006	CcSEcCtD
Orlistat—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000257	0.000599	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000257	0.000599	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000257	0.000598	CcSEcCtD
Orlistat—Pain—Hydrocortisone—systemic lupus erythematosus	0.000256	0.000597	CcSEcCtD
Orlistat—Oedema—Dexamethasone—systemic lupus erythematosus	0.000256	0.000597	CcSEcCtD
Orlistat—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000256	0.000597	CcSEcCtD
Orlistat—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000256	0.000597	CcSEcCtD
Orlistat—Oedema—Betamethasone—systemic lupus erythematosus	0.000256	0.000597	CcSEcCtD
Orlistat—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000255	0.000595	CcSEcCtD
Orlistat—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000255	0.000594	CcSEcCtD
Orlistat—Infection—Dexamethasone—systemic lupus erythematosus	0.000255	0.000593	CcSEcCtD
Orlistat—Infection—Betamethasone—systemic lupus erythematosus	0.000255	0.000593	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000254	0.000591	CcSEcCtD
Orlistat—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000254	0.000591	CcSEcCtD
Orlistat—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000253	0.000589	CcSEcCtD
Orlistat—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000253	0.000589	CcSEcCtD
Orlistat—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000251	0.000585	CcSEcCtD
Orlistat—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000251	0.000585	CcSEcCtD
Orlistat—Angioedema—Prednisone—systemic lupus erythematosus	0.00025	0.000582	CcSEcCtD
Orlistat—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000249	0.000579	CcSEcCtD
Orlistat—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000249	0.000579	CcSEcCtD
Orlistat—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000248	0.000578	CcSEcCtD
Orlistat—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000248	0.000577	CcSEcCtD
Orlistat—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000248	0.000577	CcSEcCtD
Orlistat—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000247	0.000576	CcSEcCtD
Orlistat—Malaise—Prednisone—systemic lupus erythematosus	0.000247	0.000574	CcSEcCtD
Orlistat—Vertigo—Prednisone—systemic lupus erythematosus	0.000246	0.000572	CcSEcCtD
Orlistat—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000245	0.000571	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000245	0.0012	CbGpPWpGaD
Orlistat—Urticaria—Prednisolone—systemic lupus erythematosus	0.000244	0.000568	CcSEcCtD
Orlistat—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000244	0.000567	CcSEcCtD
Orlistat—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000243	0.000566	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000243	0.00119	CbGpPWpGaD
Orlistat—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000243	0.000565	CcSEcCtD
Orlistat—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000242	0.000564	CcSEcCtD
Orlistat—Pain—Triamcinolone—systemic lupus erythematosus	0.000242	0.000562	CcSEcCtD
Orlistat—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000239	0.000556	CcSEcCtD
Orlistat—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000238	0.000555	CcSEcCtD
Orlistat—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000237	0.000552	CcSEcCtD
Orlistat—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000237	0.000552	CcSEcCtD
Orlistat—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000237	0.000552	CcSEcCtD
Orlistat—Convulsion—Prednisone—systemic lupus erythematosus	0.000237	0.000552	CcSEcCtD
Orlistat—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000237	0.000551	CcSEcCtD
Orlistat—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000236	0.00055	CcSEcCtD
Orlistat—FASN—Disease—HIST2H2AC—systemic lupus erythematosus	0.000236	0.00116	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000236	0.00116	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL2—systemic lupus erythematosus	0.000235	0.00115	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL2—systemic lupus erythematosus	0.000235	0.00115	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000233	0.00115	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000233	0.000544	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000233	0.000544	CcSEcCtD
Orlistat—PNLIP—Disease—JUNB—systemic lupus erythematosus	0.000233	0.00115	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000233	0.00115	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000233	0.00115	CbGpPWpGaD
Orlistat—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.000542	CcSEcCtD
Orlistat—Myalgia—Prednisone—systemic lupus erythematosus	0.000233	0.000542	CcSEcCtD
Orlistat—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000233	0.000542	CcSEcCtD
Orlistat—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000232	0.000541	CcSEcCtD
Orlistat—Anxiety—Prednisone—systemic lupus erythematosus	0.000232	0.00054	CcSEcCtD
Orlistat—Alopecia—Methotrexate—systemic lupus erythematosus	0.000232	0.00054	CcSEcCtD
Orlistat—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000232	0.00054	CcSEcCtD
Orlistat—Insomnia—Betamethasone—systemic lupus erythematosus	0.000232	0.00054	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000231	0.000538	CcSEcCtD
Orlistat—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000231	0.000538	CcSEcCtD
Orlistat—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.00023	0.000537	CcSEcCtD
Orlistat—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.00023	0.000536	CcSEcCtD
Orlistat—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.00023	0.000536	CcSEcCtD
Orlistat—Discomfort—Prednisone—systemic lupus erythematosus	0.00023	0.000536	CcSEcCtD
Orlistat—Mental disorder—Methotrexate—systemic lupus erythematosus	0.00023	0.000536	CcSEcCtD
Orlistat—FASN—Disease—CSK—systemic lupus erythematosus	0.00023	0.00113	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00023	0.00113	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00023	0.00113	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000229	0.00113	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CLU—systemic lupus erythematosus	0.000229	0.00112	CbGpPWpGaD
Orlistat—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000229	0.000532	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—C3—systemic lupus erythematosus	0.000228	0.00112	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—C3—systemic lupus erythematosus	0.000228	0.00112	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CSK—systemic lupus erythematosus	0.000228	0.00112	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000226	0.000527	CcSEcCtD
Orlistat—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000226	0.000525	CcSEcCtD
Orlistat—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000226	0.000525	CcSEcCtD
Orlistat—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000225	0.000525	CcSEcCtD
Orlistat—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000224	0.000522	CcSEcCtD
Orlistat—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000224	0.000521	CcSEcCtD
Orlistat—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000224	0.000521	CcSEcCtD
Orlistat—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000223	0.00052	CcSEcCtD
Orlistat—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000223	0.00052	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000223	0.00052	CcSEcCtD
Orlistat—Oedema—Prednisone—systemic lupus erythematosus	0.000223	0.00052	CcSEcCtD
Orlistat—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000223	0.000519	CcSEcCtD
Orlistat—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000223	0.000519	CcSEcCtD
Orlistat—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000223	0.000519	CcSEcCtD
Orlistat—Infection—Prednisone—systemic lupus erythematosus	0.000222	0.000516	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—P2RY12—systemic lupus erythematosus	0.000221	0.00109	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000221	0.000515	CcSEcCtD
Orlistat—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000221	0.000515	CcSEcCtD
Orlistat—Back pain—Methotrexate—systemic lupus erythematosus	0.000221	0.000515	CcSEcCtD
Orlistat—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000221	0.000515	CcSEcCtD
Orlistat—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000221	0.000514	CcSEcCtD
Orlistat—Fatigue—Betamethasone—systemic lupus erythematosus	0.000221	0.000514	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000221	0.00109	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00022	0.00108	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00022	0.00108	CbGpPWpGaD
Orlistat—Pain—Betamethasone—systemic lupus erythematosus	0.000219	0.00051	CcSEcCtD
Orlistat—Pain—Dexamethasone—systemic lupus erythematosus	0.000219	0.00051	CcSEcCtD
Orlistat—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000219	0.00051	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000218	0.00107	CbGpPWpGaD
Orlistat—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000218	0.000507	CcSEcCtD
Orlistat—Skin disorder—Prednisone—systemic lupus erythematosus	0.000217	0.000505	CcSEcCtD
Orlistat—FASN—Disease—CD247—systemic lupus erythematosus	0.000216	0.00106	CbGpPWpGaD
Orlistat—FASN—Metabolism—NAT2—systemic lupus erythematosus	0.000216	0.00106	CbGpPWpGaD
Orlistat—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000216	0.000502	CcSEcCtD
Orlistat—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000215	0.000502	CcSEcCtD
Orlistat—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000215	0.000501	CcSEcCtD
Orlistat—PNLIP—Disease—PRL—systemic lupus erythematosus	0.000215	0.00106	CbGpPWpGaD
Orlistat—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000215	0.0005	CcSEcCtD
Orlistat—Rash—Cyclosporine—systemic lupus erythematosus	0.000213	0.000496	CcSEcCtD
Orlistat—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000213	0.000495	CcSEcCtD
Orlistat—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000212	0.000494	CcSEcCtD
Orlistat—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000212	0.000494	CcSEcCtD
Orlistat—Headache—Cyclosporine—systemic lupus erythematosus	0.000211	0.000492	CcSEcCtD
Orlistat—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000211	0.000492	CcSEcCtD
Orlistat—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000211	0.000492	CcSEcCtD
Orlistat—DAGLA—Hemostasis—EP300—systemic lupus erythematosus	0.00021	0.00103	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—EP300—systemic lupus erythematosus	0.00021	0.00103	CbGpPWpGaD
Orlistat—FASN—Disease—NCF2—systemic lupus erythematosus	0.00021	0.00103	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.00021	0.000488	CcSEcCtD
Orlistat—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.00021	0.000488	CcSEcCtD
Orlistat—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000209	0.000487	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.000209	0.00103	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000208	0.00102	CbGpPWpGaD
Orlistat—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000208	0.000485	CcSEcCtD
Orlistat—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000208	0.000483	CcSEcCtD
Orlistat—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.000483	CcSEcCtD
Orlistat—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000207	0.000483	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—LYN—systemic lupus erythematosus	0.000207	0.00102	CbGpPWpGaD
Orlistat—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.00048	CcSEcCtD
Orlistat—Malaise—Methotrexate—systemic lupus erythematosus	0.000206	0.00048	CcSEcCtD
Orlistat—Vertigo—Methotrexate—systemic lupus erythematosus	0.000205	0.000478	CcSEcCtD
Orlistat—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000205	0.000478	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—CSK—systemic lupus erythematosus	0.000204	0.001	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SELE—systemic lupus erythematosus	0.000204	0.001	CbGpPWpGaD
Orlistat—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000204	0.000474	CcSEcCtD
Orlistat—Urticaria—Betamethasone—systemic lupus erythematosus	0.000204	0.000474	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000203	0.000473	CcSEcCtD
Orlistat—Dizziness—Prednisolone—systemic lupus erythematosus	0.000203	0.000473	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000203	0.000997	CbGpPWpGaD
Orlistat—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000203	0.000472	CcSEcCtD
Orlistat—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000203	0.000472	CcSEcCtD
Orlistat—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000203	0.000472	CcSEcCtD
Orlistat—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000203	0.000472	CcSEcCtD
Orlistat—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000203	0.000472	CcSEcCtD
Orlistat—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000202	0.000471	CcSEcCtD
Orlistat—Insomnia—Prednisone—systemic lupus erythematosus	0.000202	0.00047	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000201	0.000987	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000201	0.000987	CbGpPWpGaD
Orlistat—Nausea—Cyclosporine—systemic lupus erythematosus	0.0002	0.000467	CcSEcCtD
Orlistat—Paraesthesia—Prednisone—systemic lupus erythematosus	0.0002	0.000467	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—F2—systemic lupus erythematosus	0.0002	0.000983	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—F2—systemic lupus erythematosus	0.0002	0.000983	CbGpPWpGaD
Orlistat—Pruritus—Triamcinolone—systemic lupus erythematosus	0.0002	0.000465	CcSEcCtD
Orlistat—Cough—Methotrexate—systemic lupus erythematosus	0.000199	0.000464	CcSEcCtD
Orlistat—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000199	0.000464	CcSEcCtD
Orlistat—DAGLB—Hemostasis—VEGFA—systemic lupus erythematosus	0.000199	0.00098	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—VEGFA—systemic lupus erythematosus	0.000199	0.00098	CbGpPWpGaD
Orlistat—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000198	0.000462	CcSEcCtD
Orlistat—Convulsion—Methotrexate—systemic lupus erythematosus	0.000198	0.000461	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000197	0.000969	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000197	0.000969	CbGpPWpGaD
Orlistat—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000196	0.000457	CcSEcCtD
Orlistat—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.000455	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000195	0.00096	CbGpPWpGaD
Orlistat—Chest pain—Methotrexate—systemic lupus erythematosus	0.000195	0.000453	CcSEcCtD
Orlistat—Myalgia—Methotrexate—systemic lupus erythematosus	0.000195	0.000453	CcSEcCtD
Orlistat—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000194	0.000452	CcSEcCtD
Orlistat—Rash—Prednisolone—systemic lupus erythematosus	0.000194	0.000451	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000193	0.000451	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000193	0.00045	CcSEcCtD
Orlistat—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000193	0.000449	CcSEcCtD
Orlistat—Fatigue—Prednisone—systemic lupus erythematosus	0.000192	0.000448	CcSEcCtD
Orlistat—Headache—Prednisolone—systemic lupus erythematosus	0.000192	0.000448	CcSEcCtD
Orlistat—Discomfort—Methotrexate—systemic lupus erythematosus	0.000192	0.000448	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—ITGAM—systemic lupus erythematosus	0.000192	0.000942	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000191	0.000939	CbGpPWpGaD
Orlistat—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000191	0.000444	CcSEcCtD
Orlistat—Rash—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00044	CcSEcCtD
Orlistat—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00044	CcSEcCtD
Orlistat—Headache—Hydrocortisone—systemic lupus erythematosus	0.000188	0.000438	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000187	0.000921	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000187	0.000921	CbGpPWpGaD
Orlistat—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000187	0.000435	CcSEcCtD
Orlistat—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000187	0.000434	CcSEcCtD
Orlistat—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000186	0.000434	CcSEcCtD
Orlistat—Infection—Methotrexate—systemic lupus erythematosus	0.000185	0.000431	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—LYN—systemic lupus erythematosus	0.000185	0.00091	CbGpPWpGaD
Orlistat—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000184	0.000428	CcSEcCtD
Orlistat—Asthenia—Betamethasone—systemic lupus erythematosus	0.000184	0.000428	CcSEcCtD
Orlistat—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000184	0.000428	CcSEcCtD
Orlistat—DAGLA—Hemostasis—TGFB1—systemic lupus erythematosus	0.000183	0.000899	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TGFB1—systemic lupus erythematosus	0.000183	0.000899	CbGpPWpGaD
Orlistat—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000183	0.000426	CcSEcCtD
Orlistat—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000182	0.000425	CcSEcCtD
Orlistat—Nausea—Prednisolone—systemic lupus erythematosus	0.000182	0.000425	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—SH2B3—systemic lupus erythematosus	0.000182	0.000893	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PRL—systemic lupus erythematosus	0.000182	0.000893	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PRL—systemic lupus erythematosus	0.000182	0.000893	CbGpPWpGaD
Orlistat—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000181	0.000422	CcSEcCtD
Orlistat—Pruritus—Betamethasone—systemic lupus erythematosus	0.000181	0.000422	CcSEcCtD
Orlistat—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000181	0.000422	CcSEcCtD
Orlistat—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.00018	0.00042	CcSEcCtD
Orlistat—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00018	0.000418	CcSEcCtD
Orlistat—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000179	0.000417	CcSEcCtD
Orlistat—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000415	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000178	0.000876	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000178	0.000876	CbGpPWpGaD
Orlistat—Rash—Triamcinolone—systemic lupus erythematosus	0.000178	0.000415	CcSEcCtD
Orlistat—PLA2G4A—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000178	0.0148	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000178	0.0148	CbGdCrCtD
Orlistat—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Orlistat—Rash—Methylprednisolone—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Orlistat—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000178	0.000413	CcSEcCtD
Orlistat—Urticaria—Prednisone—systemic lupus erythematosus	0.000177	0.000413	CcSEcCtD
Orlistat—Headache—Triamcinolone—systemic lupus erythematosus	0.000177	0.000412	CcSEcCtD
Orlistat—Headache—Methylprednisolone—systemic lupus erythematosus	0.000177	0.000411	CcSEcCtD
Orlistat—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000176	0.000411	CcSEcCtD
Orlistat—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000176	0.000411	CcSEcCtD
Orlistat—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000175	0.000408	CcSEcCtD
Orlistat—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000175	0.000408	CcSEcCtD
Orlistat—PNLIP—Disease—JAK1—systemic lupus erythematosus	0.000172	0.000845	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000172	0.000844	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—RXRA—systemic lupus erythematosus	0.000171	0.000842	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.00017	0.000836	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.00017	0.000396	CcSEcCtD
Orlistat—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000169	0.000395	CcSEcCtD
Orlistat—Dizziness—Betamethasone—systemic lupus erythematosus	0.000169	0.000395	CcSEcCtD
Orlistat—Insomnia—Methotrexate—systemic lupus erythematosus	0.000169	0.000393	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000168	0.014	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000168	0.014	CbGdCrCtD
Orlistat—Nausea—Triamcinolone—systemic lupus erythematosus	0.000168	0.000391	CcSEcCtD
Orlistat—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000167	0.00039	CcSEcCtD
Orlistat—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000167	0.00039	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000166	0.000818	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000165	0.000812	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000165	0.0138	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000165	0.0138	CbGdCrCtD
Orlistat—FASN—Disease—JUNB—systemic lupus erythematosus	0.000165	0.000811	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000164	0.000383	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000164	0.000808	CbGpPWpGaD
Orlistat—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000164	0.000382	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000163	0.000803	CbGpPWpGaD
Orlistat—Vomiting—Betamethasone—systemic lupus erythematosus	0.000163	0.000379	CcSEcCtD
Orlistat—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000163	0.000379	CcSEcCtD
Orlistat—PNLIP—Disease—CCR5—systemic lupus erythematosus	0.000163	0.000801	CbGpPWpGaD
Orlistat—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000162	0.000378	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000162	0.000795	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000162	0.000795	CbGpPWpGaD
Orlistat—Rash—Betamethasone—systemic lupus erythematosus	0.000162	0.000376	CcSEcCtD
Orlistat—Rash—Dexamethasone—systemic lupus erythematosus	0.000162	0.000376	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000161	0.0135	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000161	0.0135	CbGdCrCtD
Orlistat—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000161	0.000376	CcSEcCtD
Orlistat—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000161	0.000376	CcSEcCtD
Orlistat—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000161	0.000375	CcSEcCtD
Orlistat—Fatigue—Methotrexate—systemic lupus erythematosus	0.000161	0.000374	CcSEcCtD
Orlistat—Headache—Dexamethasone—systemic lupus erythematosus	0.000161	0.000374	CcSEcCtD
Orlistat—Headache—Betamethasone—systemic lupus erythematosus	0.000161	0.000374	CcSEcCtD
Orlistat—Asthenia—Prednisone—systemic lupus erythematosus	0.00016	0.000373	CcSEcCtD
Orlistat—Pain—Methotrexate—systemic lupus erythematosus	0.000159	0.000371	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	0.000159	0.000781	CbGpPWpGaD
Orlistat—Pruritus—Prednisone—systemic lupus erythematosus	0.000158	0.000368	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000155	0.000763	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000154	0.000759	CbGpPWpGaD
Orlistat—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000154	0.000358	CcSEcCtD
Orlistat—PLA2G4A—Betamethasone—Prednisone—systemic lupus erythematosus	0.000153	0.0128	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000153	0.0128	CbGdCrCtD
Orlistat—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000153	0.000356	CcSEcCtD
Orlistat—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000153	0.000355	CcSEcCtD
Orlistat—Nausea—Dexamethasone—systemic lupus erythematosus	0.000152	0.000354	CcSEcCtD
Orlistat—Nausea—Betamethasone—systemic lupus erythematosus	0.000152	0.000354	CcSEcCtD
Orlistat—FASN—Disease—PRL—systemic lupus erythematosus	0.000152	0.000747	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PRL—systemic lupus erythematosus	0.00015	0.00074	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—systemic lupus erythematosus	0.00015	0.0125	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.00015	0.0125	CbGdCrCtD
Orlistat—DAGLB—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000148	0.000729	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000148	0.000729	CbGpPWpGaD
Orlistat—Urticaria—Methotrexate—systemic lupus erythematosus	0.000148	0.000345	CcSEcCtD
Orlistat—Dizziness—Prednisone—systemic lupus erythematosus	0.000148	0.000344	CcSEcCtD
Orlistat—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000147	0.000343	CcSEcCtD
Orlistat—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000147	0.000343	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000145	0.000714	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000145	0.000714	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IFNA1—systemic lupus erythematosus	0.000143	0.000702	CbGpPWpGaD
Orlistat—Vomiting—Prednisone—systemic lupus erythematosus	0.000142	0.00033	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000141	0.000694	CbGpPWpGaD
Orlistat—Rash—Prednisone—systemic lupus erythematosus	0.000141	0.000328	CcSEcCtD
Orlistat—Dermatitis—Prednisone—systemic lupus erythematosus	0.000141	0.000327	CcSEcCtD
Orlistat—Headache—Prednisone—systemic lupus erythematosus	0.00014	0.000326	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000139	0.000683	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	0.000139	0.000682	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000138	0.000677	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000138	0.000677	CbGpPWpGaD
Orlistat—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000137	0.00032	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000136	0.000667	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000136	0.000667	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000135	0.000664	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000135	0.000662	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000135	0.000662	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—C3—systemic lupus erythematosus	0.000134	0.000661	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—C3—systemic lupus erythematosus	0.000134	0.000661	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000134	0.000659	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD80—systemic lupus erythematosus	0.000134	0.000659	CbGpPWpGaD
Orlistat—Asthenia—Methotrexate—systemic lupus erythematosus	0.000134	0.000312	CcSEcCtD
Orlistat—Nausea—Prednisone—systemic lupus erythematosus	0.000133	0.000309	CcSEcCtD
Orlistat—Pruritus—Methotrexate—systemic lupus erythematosus	0.000132	0.000307	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	0.000131	0.000646	CbGpPWpGaD
Orlistat—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000128	0.000297	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000127	0.000625	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000127	0.000624	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000125	0.000616	CbGpPWpGaD
Orlistat—Dizziness—Methotrexate—systemic lupus erythematosus	0.000123	0.000287	CcSEcCtD
Orlistat—FASN—Disease—JAK1—systemic lupus erythematosus	0.000122	0.000598	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	0.000121	0.000596	CbGpPWpGaD
Orlistat—FASN—Metabolism—RXRA—systemic lupus erythematosus	0.000121	0.000595	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—JAK1—systemic lupus erythematosus	0.00012	0.000592	CbGpPWpGaD
Orlistat—Vomiting—Methotrexate—systemic lupus erythematosus	0.000119	0.000276	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—F2—systemic lupus erythematosus	0.000118	0.00058	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—F2—systemic lupus erythematosus	0.000118	0.00058	CbGpPWpGaD
Orlistat—Rash—Methotrexate—systemic lupus erythematosus	0.000118	0.000274	CcSEcCtD
Orlistat—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000117	0.000274	CcSEcCtD
Orlistat—Headache—Methotrexate—systemic lupus erythematosus	0.000117	0.000272	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000117	0.000574	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	0.000115	0.000568	CbGpPWpGaD
Orlistat—FASN—Disease—CCR5—systemic lupus erythematosus	0.000115	0.000566	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	0.000114	0.000563	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000114	0.000561	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CD80—systemic lupus erythematosus	0.000113	0.000557	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CD80—systemic lupus erythematosus	0.000113	0.000557	CbGpPWpGaD
Orlistat—PNLIP—Disease—TYK2—systemic lupus erythematosus	0.000113	0.000556	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000112	0.000553	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	0.000112	0.000552	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—C3—systemic lupus erythematosus	0.000111	0.000548	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS3—systemic lupus erythematosus	0.000111	0.000546	CbGpPWpGaD
Orlistat—Nausea—Methotrexate—systemic lupus erythematosus	0.000111	0.000258	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000109	0.000538	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARG—systemic lupus erythematosus	0.000108	0.000531	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—JAK1—systemic lupus erythematosus	0.000108	0.00053	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000105	0.000517	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000105	0.000517	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD4—systemic lupus erythematosus	0.000102	0.000503	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—systemic lupus erythematosus	0.000102	0.000499	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2RA—systemic lupus erythematosus	0.000101	0.000495	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	0.0001	0.000493	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—F2—systemic lupus erythematosus	9.78e-05	0.000481	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	9.73e-05	0.000478	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ALB—systemic lupus erythematosus	9.72e-05	0.000478	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN1B—systemic lupus erythematosus	9.61e-05	0.000473	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TYK2—systemic lupus erythematosus	9.56e-05	0.00047	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TYK2—systemic lupus erythematosus	9.56e-05	0.00047	CbGpPWpGaD
Orlistat—FASN—Disease—CD80—systemic lupus erythematosus	9.48e-05	0.000466	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CD80—systemic lupus erythematosus	9.38e-05	0.000461	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOS3—systemic lupus erythematosus	9.38e-05	0.000461	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOS3—systemic lupus erythematosus	9.38e-05	0.000461	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	9.37e-05	0.000461	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NOS3—systemic lupus erythematosus	9.29e-05	0.000457	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NAT2—systemic lupus erythematosus	9.27e-05	0.000456	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	8.93e-05	0.000439	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN1A—systemic lupus erythematosus	8.87e-05	0.000436	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—F2—systemic lupus erythematosus	8.76e-05	0.000431	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL2—systemic lupus erythematosus	8.72e-05	0.000429	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.55e-05	0.00042	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—systemic lupus erythematosus	8.5e-05	0.000418	CbGpPWpGaD
Orlistat—PNLIP—Disease—EP300—systemic lupus erythematosus	8.44e-05	0.000415	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.13e-05	0.000399	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.13e-05	0.000399	CbGpPWpGaD
Orlistat—FASN—Disease—TYK2—systemic lupus erythematosus	8e-05	0.000393	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.98e-05	0.000392	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—systemic lupus erythematosus	7.95e-05	0.000391	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—systemic lupus erythematosus	7.95e-05	0.000391	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TYK2—systemic lupus erythematosus	7.92e-05	0.000389	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—systemic lupus erythematosus	7.91e-05	0.000389	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—systemic lupus erythematosus	7.91e-05	0.000389	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—systemic lupus erythematosus	7.85e-05	0.000386	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—systemic lupus erythematosus	7.77e-05	0.000382	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TLR9—systemic lupus erythematosus	7.75e-05	0.000381	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—systemic lupus erythematosus	7.65e-05	0.000376	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—systemic lupus erythematosus	7.53e-05	0.00037	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—systemic lupus erythematosus	7.53e-05	0.00037	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.51e-05	0.000369	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.5e-05	0.000369	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.5e-05	0.000369	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.37e-05	0.000362	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—systemic lupus erythematosus	7.34e-05	0.000361	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—systemic lupus erythematosus	7.28e-05	0.000358	CbGpPWpGaD
Orlistat—FASN—Disease—CD4—systemic lupus erythematosus	7.23e-05	0.000356	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—systemic lupus erythematosus	7.18e-05	0.000353	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EP300—systemic lupus erythematosus	7.13e-05	0.000351	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EP300—systemic lupus erythematosus	7.13e-05	0.000351	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	7.12e-05	0.00035	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.09e-05	0.000349	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EP300—systemic lupus erythematosus	7.07e-05	0.000348	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—systemic lupus erythematosus	6.96e-05	0.000342	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CSK—systemic lupus erythematosus	6.91e-05	0.00034	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—systemic lupus erythematosus	6.87e-05	0.000338	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1B—systemic lupus erythematosus	6.8e-05	0.000334	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.76e-05	0.000332	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.76e-05	0.000332	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.73e-05	0.000331	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.62e-05	0.000326	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—systemic lupus erythematosus	6.59e-05	0.000324	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—systemic lupus erythematosus	6.58e-05	0.000323	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NCF2—systemic lupus erythematosus	6.32e-05	0.000311	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1A—systemic lupus erythematosus	6.28e-05	0.000309	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LYN—systemic lupus erythematosus	6.28e-05	0.000309	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—systemic lupus erythematosus	6.24e-05	0.000307	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.21e-05	0.000305	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.2e-05	0.000305	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.2e-05	0.000305	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.18e-05	0.000304	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.16e-05	0.000303	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—systemic lupus erythematosus	6.01e-05	0.000296	CbGpPWpGaD
Orlistat—FASN—Disease—EP300—systemic lupus erythematosus	5.97e-05	0.000294	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EP300—systemic lupus erythematosus	5.91e-05	0.000291	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—systemic lupus erythematosus	5.9e-05	0.00029	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.86e-05	0.000288	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.8e-05	0.000285	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.78e-05	0.000284	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—C3—systemic lupus erythematosus	5.73e-05	0.000282	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.6e-05	0.000275	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—systemic lupus erythematosus	5.53e-05	0.000272	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EP300—systemic lupus erythematosus	5.29e-05	0.00026	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—RXRA—systemic lupus erythematosus	5.2e-05	0.000255	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—systemic lupus erythematosus	5.19e-05	0.000255	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.14e-05	0.000253	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.05e-05	0.000248	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—F2—systemic lupus erythematosus	5.03e-05	0.000247	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—systemic lupus erythematosus	5.01e-05	0.000247	CbGpPWpGaD
Orlistat—FASN—Metabolism—EP300—systemic lupus erythematosus	5e-05	0.000246	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.96e-05	0.000244	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.82e-05	0.000237	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.71e-05	0.000232	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—systemic lupus erythematosus	4.67e-05	0.00023	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—systemic lupus erythematosus	4.67e-05	0.00023	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—systemic lupus erythematosus	4.6e-05	0.000226	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRL—systemic lupus erythematosus	4.57e-05	0.000225	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.48e-05	0.00022	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.07e-05	0.0002	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—systemic lupus erythematosus	3.91e-05	0.000192	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—systemic lupus erythematosus	3.87e-05	0.00019	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAK1—systemic lupus erythematosus	3.65e-05	0.00018	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR5—systemic lupus erythematosus	3.46e-05	0.00017	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.41e-05	0.000168	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.39e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—C3—systemic lupus erythematosus	3.38e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—systemic lupus erythematosus	3.28e-05	0.000161	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—F2—systemic lupus erythematosus	2.97e-05	0.000146	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—systemic lupus erythematosus	2.95e-05	0.000145	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CD80—systemic lupus erythematosus	2.85e-05	0.00014	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—systemic lupus erythematosus	2.82e-05	0.000139	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.65e-05	0.00013	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—systemic lupus erythematosus	2.58e-05	0.000127	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.4e-05	0.000118	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.36e-05	0.000116	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.17e-05	0.000107	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EP300—systemic lupus erythematosus	2.15e-05	0.000106	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.04e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—systemic lupus erythematosus	2e-05	9.83e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.99e-05	9.79e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.89e-05	9.31e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.89e-05	9.27e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EP300—systemic lupus erythematosus	1.79e-05	8.83e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.7e-05	8.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.56e-05	7.67e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.22e-05	5.98e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—systemic lupus erythematosus	1.18e-05	5.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	7.68e-06	3.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.91e-06	3.4e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	6.61e-06	3.25e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	6.04e-06	2.97e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	5.03e-06	2.47e-05	CbGpPWpGaD
